Catheter Precision Inc (AMEX:VTAK)

$ 0.4914 -0.0841 (-14.61%) Market Cap: 3.72 Mil Enterprise Value: 3.12 Mil PE Ratio: 1.76 PB Ratio: 0.20 GF Score: 54/100

Q1 2022 Ra Medical Systems Inc Earnings Call Transcript
May 16, 2022

$13.85 (+0.11%)

Earnings
Q4 2021 Ra Medical Systems Inc Earnings Call Transcript
Mar 23, 2022

$25.51 (+0.02%)

Earnings
Q3 2021 Ra Medical Systems Inc Earnings Call Transcript
Nov 15, 2021

$139 (-2.46%)

Earnings
Q2 2021 Ra Medical Systems Inc Earnings Call Transcript
Aug 16, 2021

$149.5 (-9.12%)

Earnings
Q1 2021 Ra Medical Systems Inc Earnings Call Transcript
May 11, 2021

$166 (-8.03%)

Earnings
Q4 2020 Ra Medical Systems Inc Earnings Call Transcript
Mar 16, 2021

$305 (+0.83%)

Earnings
Ra Medical Systems, Inc. - Special Call Transcript
Dec 03, 2020
Q3 2020 Ra Medical Systems Inc Earnings Call Transcript
Nov 12, 2020

$246.5 (-4.55%)

Earnings
Q2 2020 Ra Medical Systems Inc Earnings Call Transcript
Aug 11, 2020

$432.63 (-6.46%)

Earnings
Q1 2020 Ra Medical Systems Inc Earnings Call Transcript
May 13, 2020

$1196.38 (-8.85%)

Earnings
Q4 2019 Ra Medical Systems Inc Earnings Call Transcript
Mar 10, 2020

$1762.5 (-6.00%)

Earnings

Q4 2021 Ra Medical Systems Inc Earnings Call Transcript

Mar 23, 2022 / 08:30PM GMT

Release Date Price: $25.51 (+0.02%)

Transcript 10-K8-K

Operator

Good afternoon, and welcome to the Ra Medical Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Jody Cain. Please go ahead.

Jody Cain;Heilshorn;Associates

Lippert;Inc. - SVP of LA

/& -

This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from Ra Medical are Will McGuire, Chief Executive Officer; and Andrew Jackson, Chief Financial Officer.

Earlier today, Ra Medical issued a news release announcing financial results for the 2021 fourth quarter and full year. If you've not received this news release or if you'd like to be added to the company's e-mail distribution list, please contact LHA at (310) 691-7100 and speak with Daniel Chertock. You can also sign up for e-mail alerts and access the news releases in the Investor Relations section of the Ra Medical website at ir.ramed.com.

During this call or in response to listener questions, management will be making a number of forward

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.